Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1095145


Drug-Eluting Stents - Global Market Opportunities


Description: Increasing acceptance of stents as viable treatment option, expanding patient population seeking drug-eluting stents, and higher reimbursement coverage are key factors driving growth of drug-eluting stents. Development of innovative treatment methods and preventive measures for coronary diseases, obesity, and diabetes are few factors influencing the long-term growth prospects of the drug-eluting stents market.

Through registering significant growth in the recent past, incidents of adverse effects such as in-stent thrombosis is expected to significantly restrict future market growth. In-stent thrombosis is a common long-term adverse effect of DES where patients develop clots. Although in-stent thrombosis cases occur rarely, they are highly fatal. On the contrary, bare-metal stents do not pose such threats thereby augmenting its usage in interventional management. The rise in in-stent thrombosis cases paves the way for anti-thrombotic therapies. Moreover, drug-eluting stents faces stiff competition from advanced and safer technologies such as tiny wire mesh tubes.

These and other market data and trends are presented in "Drug-Eluting Stents: Global Market Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.


Contents: DRUG-ELUTING STENTS


CONTENTS


1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3

2. MARKET OVERVIEW 4
Current and Future Analysis 4
Major Issues and Trends 5
Drug-Eluting Stents Transforming the Scenario of
Interventional- Cardiology Market 5
Adverse Effects Restrict Market Growth 5
Innovation and Development Drive Market Growth 6
High Price of DES - A Major Impediment to Rapid Development 6
Potential Decline in Hospital Revenues 6
Glaring Lack of Health-Related Initiatives World Over 7
Bioabsorbable Stents Closer to Reality Than Expected 7

3. PRODUCT FACTS 8
Major Drug-Eluting Stent Products in the Market 8

4. COMPETITIVE SCENARIO 9
Drug-Eluting Stents-Competitive Arena 9
Market Dominated by Small Band of Players 10
Cordis (A Johnson & Johnson Company) 10
Cypher Leads the Drug-Eluting Stent Market 10
Boston Scientific 10
Taxus Beats Cypher in the US 10

5. REGULATORY ENVIRONMENT 11
FDA Framework 11
FDA to Monitor Drug-Eluting Stents 11
Issues Raised by FDA Regarding the Safety of Stent 11

6. CORPORATE DEVELOPMENTS 11
MIV Therapeutics Acquires Biosync Scientific 11
J & J Acquires Conor Medsystems 12
Lombard Collaborates With S&N 12
India Establishes Asia’s first Catheter and Stent Unit 12
Abbott Requests FDA Approval for Xience 12
Brookwood and TTV Start Joint Venture 12
SurModics Acquires Brookwood Pharmaceuticals, Inc 13
ARIAD Collaborates with ICON Medical 13
Biosensors Acquires 50% Stake in JWMS 13
Boston Completes European and Intercontinental Enrollment Phases 14
FDA Approves Boston Scientifis’s Taxus Stent with Extended
Shelf Life 14
Abbott Launches Drug-Eluting Coronary Stent 14
Boston Introduces Taxus(R) Express2(TM) in Japan 14

7. MAJOR PLAYERS 15
Abbott Vascular (USA) 15
Angiotech Pharmaceuticals, Inc (Canada) 15
AngioDynamics® Inc. (USA) 15
Boston Scientific, Inc. (USA) 15
Boston Scientific Cardiac Rhythm Management (USA) 16
Biocompatibles International Plc (UK) 16
Biosensors International Pte Ltd. (Singapore) 16
Cordis Corporation (USA) 16
Implant Sciences Corporation (USA) 17
Medtronic, Inc. (USA) 17
MIV Therapeutics Inc (Canada) 17
SurModics, Inc. (USA) 17

8. GLOBAL MARKET ANALYTICS 18

9. THE UNITED STATES 19
Issues and Trends 19
US Healthcare Ideology 19
The Important Role of Medicaid in the US 19
Drug-Eluting Stents-Competitive Arena 20
Leading DES Products in the Market 20
Cypher - First to Market 20
Taxus Beats Cypher 20
Regulatory Environment 20
FDA Framework 20
Issues Raised by FDA Regarding the Safety of Stent 21

10. JAPAN 21
Healthcare System in Japan 21

11. EUROPE 23

a. France 25

b. Germany 25

c. Italy 26

d. The United Kingdom 27

e. Spain 27

f. Rest of Europe 28

12. REST OF WORLD 29


EXHIBITS

Table 1: Percentage Breakdown of Leading Drug Eluting Stents
Brands in the World-2006

Table 2: Percentage Breakdown of Leading Players in the Global
Drug Eluting Stents Market -2008

Table 3: Global Drug-Eluting Stents Market by Region for the
Period 2007-2015 (Sales in US$ Million)

Table 4: Percentage Breakdown of Global Drug-Eluting Stents
Market by Region for the Years 2008 & 2012

Table 5: Percentage Breakdown of Major Players in the US
Market for Drug Eluting Stents - 2008

Table 6: Drug-Eluting Stents Market in the US: 2007-2015
(Sales in US$ Million)

Table 7: Percentage Breakdown of Major Players in the Japanese
Market for Drug Eluting Stents -2008

Table 8: Drug-Eluting Stents Market in Japan: 2007-2015 (Sales
in US$ Million)

Table 9: Percentage Breakdown of Major Players in the European
Market for Drug Eluting Stents -2008

Table 10: Drug-Eluting Stents Market by Region in Europe:
2007-2015 (Sales in US$ Million)

Table 11: Percentage Breakdown of Drug-Eluting Stents Market
by Region in Europe for the Years 2008 & 2012

Table 12: Drug-Eluting Stents Market in France: 2007-2015
(Sales in US$ Million)

Table 13: Drug-Eluting Stents Market in Germany: 2007-2015
(Sales in US$ Million)

Table 14: Drug-Eluting Stents Market in Italy: 2007-2015
(Sales in US$ Million)

Table 15: Drug-Eluting Stents Market in the UK: 2007-2015
(Sales in US$ Million)

Table 16: Drug-Eluting Stents Market in Spain: 2007-2015
(Sales in US$ Million)

Table 17: Drug-Eluting Stents Market in Rest of Europe:
2007-2015 (Sales in US$ Million)

Table 18: Drug-Eluting Stents Market in Rest of World:
2007-2015 (Sales in US$ Million)


COMPANIES PROFILED




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1095145

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 04:44:21
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Drug-Eluting Stents - Global Market Opportunities
Web Address:
http://www.researchandmarkets.com/reports/1095145
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,651.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 04:44:21

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)